UnitedHealth Group (UNH) has recently seen its stock price climb significantly, a trend that began after a period of downward correction. While Warren Buffett's notable investment in the company has drawn considerable attention, the stock's robust performance appears to be rooted in a combination of strategic corporate decisions and broader investor interest. The company's management is diligently working to refine its business model, with a particular focus on enhancing profitability across its diverse service lines. This proactive approach, coupled with a favorable market sentiment, positions UNH for sustained growth.
Management's aggressive strategies for 2026 involve a comprehensive repricing of all business lines. This includes shedding over 600,000 unprofitable members and shifting focus towards higher-margin products. Such moves are crucial in navigating the current landscape of escalating medical costs. This strategic realignment aims to bolster the company's financial health and optimize its operational efficiency.
The current trading valuation of UNH, hovering around 15 times forward earnings, is reminiscent of its 2020 levels. This valuation suggests a potential for significant appreciation, especially when considering its projected earnings per share (EPS) growth of 11-12%. This scenario mirrors past recoveries where similar growth trajectories led to substantial gains for shareholders.
Beyond the well-publicized investment by Warren Buffett's Berkshire Hathaway, other prominent investors such as Michael Burry, Renaissance Technologies, and even former President Trump have reportedly acquired positions in UnitedHealth. This broad institutional interest underscores a collective belief in the company's recovery prospects and its undervalued status in the market. It suggests a widespread recognition that UNH was oversold and now presents a compelling investment opportunity.
Looking ahead, UnitedHealth's guidance of at least $16 EPS for 2025 and an 11% revenue growth target paint a promising picture. Market consensus anticipates a meaningful acceleration in earnings during 2026-2027. This positive outlook is a key driver behind the stock's current momentum, reinforcing confidence in its long-term financial trajectory.
UnitedHealth's resilience and strategic initiatives are paving the way for a continued upward trend. The combination of internal restructuring, strong earnings projections, and diverse institutional backing creates a compelling narrative for its ongoing market rally.
Unlocking Value: The FMI All Cap Equity Approach to Market Dynamics
Investment Philosophy: Adopting a Business Owner's Mindset
At the core of our investment strategy is the belief in approaching every opportunity with the meticulousness of a business owner. This means undertaking exhaustive research into the financial underpinnings of target companies and thoroughly assessing the caliber of their leadership teams. Our due diligence aims to uncover intrinsic value, rather than merely tracking market fluctuations.
Strategic Focus: Valuing Assets for Long-Term Growth
A cornerstone of our methodology is a strong emphasis on low absolute and relative valuations. This disciplined focus on identifying undervalued assets is critical to the execution of our investment framework. We believe that securing positions in businesses trading below their true worth provides a significant margin of safety and potential for substantial long-term returns.
Recent Portfolio Additions: Expanding Strategic Holdings
In line with our active management philosophy, a 1.5% stake in Gates Industrial Corp. was strategically acquired in June 2025. This addition reflects our ongoing commitment to identifying and investing in companies that align with our rigorous valuation criteria and growth expectations, further diversifying the fund's holdings.
Performance Overview: A Look at Recent Returns
The FMI All Cap Equity Fund has demonstrated consistent performance across various timeframes. For the most recent quarter, the fund achieved a gross return of 4.22%, with a year-to-date return of 5.15%. Over longer horizons, the fund has delivered robust results: 9.90% over one year, 14.54% over three years, and 14.07% over five years, underscoring the effectiveness of our long-term investment strategy.
Long-Term Trajectory: Sustained Value Creation
Reflecting on a decade of operations, the fund has maintained an impressive 10-year gross return of 10.58%. Since its inception, the fund's gross return stands at 10.30%, a testament to its enduring commitment to value-oriented investing and its ability to generate significant returns for investors over extended periods. These figures highlight the fund's capacity for sustained capital appreciation.
Unleashing Potential: TKO's Strategic Ascent in Sports Entertainment
Reaffirming the Buy: A Look at TKO's Strong Fundamentals
My earlier endorsement of TKO Group Holdings in April was based on the company's solid foundational strength. Recent developments have only reinforced this conviction, with the company continuing to exhibit robust performance indicators. The latest financial reports underscore a healthy operational environment, setting the stage for continued success and validating the initial bullish stance on the stock.
Q2 Triumphs and Elevated Expectations for FY25
TKO's second-quarter results have been nothing short of impressive, providing tangible evidence of its operational efficiency and market dominance. These strong figures have prompted an upward revision of the fiscal year 2025 guidance, signaling heightened confidence in the company's future earnings potential. This positive adjustment reflects TKO's capacity to not only meet but exceed market expectations.
Paramount Partnership: A Game-Changer for UFC's Media Future
A pivotal moment for TKO is the monumental seven-year, $7.7 billion media rights agreement with Paramount for the UFC. This landmark deal is set to significantly broaden the UFC's reach and unlock new avenues for content monetization. Such a strategic partnership ensures long-term revenue visibility and reinforces the UFC's position as a premier global sports property.
Shareholder Value: The Impact of a $2 Billion Repurchase Plan
TKO's commitment to delivering superior shareholder returns is exemplified by its robust free cash flow generation, which supports an impressive $2 billion share repurchase program. This initiative is designed to enhance shareholder value by reducing the number of outstanding shares, thereby increasing earnings per share and projecting mid-teens percentage returns. It signifies a strong belief in the company's intrinsic value and future profitability.